Clinical Trial Status Cagrilintide has completed Phase 3 clinical trials (the REDEFINE program) by Novo Nordisk
Pediatric Crohn's disease and multisystem inflammatory syndrome in children (MIS-C) and COVID-19 treated with infliximab
^ Determination of blood total, reduced, and oxidized glutathione in pediatric subjects
In such cases, second line therapeutics typically consist of biologic DMARDs designed to modulate specific cellular and molecular inflammatory pathways, targeting B cells (anti-CD20 rituximab), pro-inflammatory cytokines (tumor necrosis factor [TNF]- adalimumab) or its receptors (interleukin-6 receptor [IL-6R] tocilizumab), among others (66)
Overall, the safety profile of tirzepatide in Japanese patients aligns with global findings, confirming its general tolerability as an add-on therapy to oral antihyperglycemic medications [18]
Quick Takeaways: Semaglutide is a dual-purpose medication used for managing type 2 diabetes and obesity